STORM in the News
BioCentury Emerging Company Profile: Taking RNA epigenetics by storm
STORM Therapeutics Limited is the first company to come out of the budding field of RNA epigenetics, and is targeting RNA-modifying enzymes for cancer.
BioCentury article